China Universal Asset Management Company’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Buy |
|
|||||
|
2025
Q1 | $245K | Sell |
|
|||||
|
2024
Q4 | $217K | Buy |
|
|||||
|
2024
Q3 | $270K | Buy |
|
|||||
|
2024
Q2 | $96.9K | Sell |
|
|||||
|
2024
Q1 | $189K | Buy |
|
|||||
|
2023
Q4 | $60.9K | Buy |
|
|||||
|
2023
Q3 | $9.27K | Buy |
|
|||||
|
2023
Q2 | $8.32K | Sell |
|
|||||
|
2023
Q1 | $8.27K | Buy |
|
|||||
|
2022
Q4 | $8.13K | Buy |
|
|||||
|
2022
Q3 | $2K | Buy |
|